Tokyo Tape
Sign in
← Nippon Kayaku

Quarterly report · Q1

4272.TEDINET S100RJ1O
Period2023-04-01 → 2023-06-30
Filed2023-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥48.6bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥198.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥48.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥2.3bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥6.4bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥4.2bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥23.0bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥8.6bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥4.2bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥8.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥2.7bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥15.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.7bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥6.0bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥343.0bnat 2023-06-30Cons.Assets
Total assets¥322.9bnat 2023-03-31Cons.Assets
Total assets¥325.4bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥79.5bnat 2023-06-30Cons.Liabilities
Total liabilities¥67.8bnat 2023-03-31Cons.Liabilities
Net assets / equity¥263.5bnat 2023-06-30Cons.Net assets
Net assets / equity¥255.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥252.5bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥56.2bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥48.1bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥16.062023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥89.362022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.412022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥16.042023-04-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥89.332022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥35.42022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio76.5%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio78.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥9m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥9m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥2.0bn
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue2023-04-01 → 2023-06-30¥14.0bn
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue external2023-04-01 → 2023-06-30¥13.9bn
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥9m
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.2bn
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentrevenue2023-04-01 → 2023-06-30¥15.4bn
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentrevenue external2023-04-01 → 2023-06-30¥15.4bn
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥0
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.6bn
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue2023-04-01 → 2023-06-30¥19.3bn
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue external2023-04-01 → 2023-06-30¥19.3bn
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.5bn
—segment totalrevenue2023-04-01 → 2023-06-30¥48.6bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥48.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥9m
—segment totalsegment profit2023-04-01 → 2023-06-30¥4.4bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥51m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥51m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥1.9bn
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue2022-04-01 → 2022-06-30¥16.9bn
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue external2022-04-01 → 2022-06-30¥16.8bn
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥42m
jpcrp040300-q1r_E00836-000Fine Chemicals Business Unitreportable segmentsegment profit2022-04-01 → 2022-06-30¥3.5bn
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentrevenue2022-04-01 → 2022-06-30¥14.8bn
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentrevenue external2022-04-01 → 2022-06-30¥14.8bn
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥0
jpcrp040300-q1r_E00836-000Life Science Business Unitreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.8bn
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue2022-04-01 → 2022-06-30¥16.7bn
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue external2022-04-01 → 2022-06-30¥16.7bn
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥8m
jpcrp040300-q1r_E00836-000Mobility And Imaging Business Unitreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.9bn
—segment totalrevenue2022-04-01 → 2022-06-30¥48.3bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥48.3bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥51m
—segment totalsegment profit2022-04-01 → 2022-06-30¥8.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 376
ItemContextValueUnit
Net salesPrior1YTDDuration_ReportableSegmentsMember48348000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-51000000JPY
Net salesPrior1YTDDuration48296000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember1929000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember3492000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00836-000LifeScienceBusinessUnitReportableSegmentMember2848000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember8270000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-1889000000JPY
Operating incomePrior1YTDDuration6380000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember19250000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember13946000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00836-000LifeScienceBusinessUnitReportableSegmentMember15387000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember48584000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration48584000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember9000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00836-000LifeScienceBusinessUnitReportableSegmentMember0JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember9000000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-9000000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember19250000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember13956000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00836-000LifeScienceBusinessUnitReportableSegmentMember15388000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember48594000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-9000000JPY
Net salesCurrentYTDDuration48584000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember1479000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember1245000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00836-000LifeScienceBusinessUnitReportableSegmentMember1638000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember4363000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-2029000000JPY
Operating incomeCurrentYTDDuration2333000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-08-09
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第167期第１四半期(自　2023年４月１日　至　2023年６月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)日本化薬株式会社
Company name in english cover pageFilingDateInstantNIPPON KAYAKU CO.,LTD.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　涌元　厚宏
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区丸の内二丁目１番１号
Telephone number address of registered headquarter cover pageFilingDateInstant03(6731)5200
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役員　経理部長　川村　勉
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区丸の内二丁目１番１号
Telephone number nearest place of contact cover pageFilingDateInstant03(6731)5842
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役員　経理部長　川村　勉
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00836
Fund codeFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass